NCT00567372|WithdrawnPhase 4
Study Stopped
Poor accrual
POSTERIOR SUB-TENON'S Avastin
POSTERIOR SUB-TENON'S CAPSULE INJECTION OF BEVACIZUMAB FOR TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA
Loading search results
Sponsor study identifier
interventional
0
1 country
1
Study Start
June 2008
Actual (reported)Primary Completion
November 2008
Actual (reported)Study Completion
June 2009
Actual (reported)Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 30, 2007
Actual (reported)December 4, 2007
Actual (reported)June 2008
Actual (reported)November 2008
Actual (reported)June 2009
Actual (reported)macular volume
baseline, 3,6 and 12 weeks
macular thickness
baseline,3,6 and 12 weeks
best corrected visual acuity
baseline, 3,6 and 12 weeks
a single posterior sub-tenon's capsule injection of bevacizumab (2.5 mg /0.1ml)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Asociación para Evitar la Ceguera en Mexico
Mexico City, Mexico City, 04030, Mexico
Sandra Vera, MD
Asociación para Evitar la Ceguera en Mexico
Hugo Quiroz-Mercado, MD
Denver Health Medical Center
Adai Pérez-Montesinos, MD
Asociación para Evitar la Ceguera en Mexico
0 participants (actual enrollment reported by the registry).
First Submitted
November 30, 2007
First Posted
December 4, 2007
Study Start
June 2008
Actual (reported)Primary Completion
November 2008
Actual (reported)Study Completion
June 2009
Actual (reported)Last Updated
June 3, 2024
Record last verified: 2024-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: